Ascentage Pharma Group Stock Performance
| ASPHF Stock | USD 8.48 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Ascentage Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Ascentage Pharma is expected to be smaller as well. At this point, Ascentage Pharma has a negative expected return of -0.12%. Please make sure to confirm Ascentage Pharma's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Ascentage Pharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Ascentage Pharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
| Begin Period Cash Flow | 1 B | |
| Total Cashflows From Investing Activities | -466.5 M |
Ascentage |
Ascentage Pharma Relative Risk vs. Return Landscape
If you would invest 932.00 in Ascentage Pharma Group on November 11, 2025 and sell it today you would lose (84.00) from holding Ascentage Pharma Group or give up 9.01% of portfolio value over 90 days. Ascentage Pharma Group is currently producing negative expected returns and takes up 2.469% volatility of returns over 90 trading days. Put another way, 22% of traded pink sheets are less volatile than Ascentage, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Ascentage Pharma Target Price Odds to finish over Current Price
The tendency of Ascentage Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.48 | 90 days | 8.48 | about 64.74 |
Based on a normal probability distribution, the odds of Ascentage Pharma to move above the current price in 90 days from now is about 64.74 (This Ascentage Pharma Group probability density function shows the probability of Ascentage Pink Sheet to fall within a particular range of prices over 90 days) .
Ascentage Pharma Price Density |
| Price |
Predictive Modules for Ascentage Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascentage Pharma. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ascentage Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ascentage Pharma is not an exception. The market had few large corrections towards the Ascentage Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ascentage Pharma Group, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ascentage Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.16 | |
β | Beta against Dow Jones | 0.45 | |
σ | Overall volatility | 0.37 | |
Ir | Information ratio | -0.08 |
Ascentage Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascentage Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascentage Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ascentage Pharma generated a negative expected return over the last 90 days | |
| Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M. | |
| Ascentage Pharma generates negative cash flow from operations | |
| About 27.0% of the company shares are held by company insiders |
Ascentage Pharma Fundamentals Growth
Ascentage Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ascentage Pharma, and Ascentage Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ascentage Pink Sheet performance.
| Return On Equity | -0.7 | |||
| Return On Asset | -0.22 | |||
| Operating Margin | (8.63) % | |||
| Current Valuation | 844.8 M | |||
| Shares Outstanding | 287.77 M | |||
| Price To Book | 12.28 X | |||
| Price To Sales | 14.53 X | |||
| Revenue | 27.91 M | |||
| EBITDA | (802.15 M) | |||
| Total Debt | 1.03 B | |||
| Book Value Per Share | 3.39 X | |||
| Cash Flow From Operations | (604.68 M) | |||
| Earnings Per Share | (0.46) X | |||
| Total Asset | 2.94 B | |||
About Ascentage Pharma Performance
By analyzing Ascentage Pharma's fundamental ratios, stakeholders can gain valuable insights into Ascentage Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ascentage Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ascentage Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Ascentage Pharma performance evaluation
Checking the ongoing alerts about Ascentage Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ascentage Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ascentage Pharma generated a negative expected return over the last 90 days | |
| Ascentage Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.91 M. Net Loss for the year was (782.42 M) with profit before overhead, payroll, taxes, and interest of 24.58 M. | |
| Ascentage Pharma generates negative cash flow from operations | |
| About 27.0% of the company shares are held by company insiders |
- Analyzing Ascentage Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ascentage Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Ascentage Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ascentage Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ascentage Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ascentage Pharma's pink sheet. These opinions can provide insight into Ascentage Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ascentage Pink Sheet analysis
When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |